Back to Screener

Consumer Defensive

EC Healthcare(UNHLF)

Live Price

Offline

$0.086

+0.00% today

1Y Change

-48.10%

Window

Jun 23, 2025 โ†’ Jun 16, 2026

Market Cap
$550.00M
Revenue Growth
-1.7%
EPS Growth
-775.0%
Dividend Yield
0.0%

Coverage: 253 bars ยท Jun 23, 2025 โ†’ Jun 16, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

EC Healthcare (UNHLF) is a Consumer Defensive stock with a market cap of $550.00M and listed on OTC. The stock last traded around $0.09 and down 48.1% across the available one-year price window (Jun 23, 2025 โ†’ Jun 16, 2026). Baseline metrics include revenue growth of -1.7%, EPS growth of -775.0%, a dividend yield of 0.0%. What stands out right now is revenue -1.7%, EPS -775.0%, free cash flow +30.0% with operating margin -6.0% and ROIC -5.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines UNHLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-1.7% vs +1.7% peer median

Operating Margin

Below sector median

-6.0% vs +6.6% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

The operating picture looks softer than before

Revenue is at -1.7% and EPS is at -775.0%, with operating margin around -6.0%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

UNHLF

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

UNHLF Max Drawdown

-63.85%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for UNHLF and SPY.

Calendar-year return history is still loading or unavailable.
EC Healthcare logo

Company Overview

EC Healthcare

Other OTC

EC Healthcare, an investment holding company, engages in the provision of medical and healthcare services in Hong Kong, Macau, and the People's Republic of China. The company operates through three segments: Medical, Aesthetic Medical and Beauty and Wellness, and Others. It provides quasi-medical, beauty and wellness, medical imaging, medical surgery, aesthetic medical beauty, aesthetic medical, dental, hair treatment, vaccine, chiropractic, psychological, and orthopedics services. It also offers administrative, management, laboratory testing, performance marketing, marketing, and travel agency services; sells beauty and skincare products; operates in healthcare machines and property investment holding businesses; and provides multi-channel networking and related services, and veterinary services. The company offers products and services primarily under private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Mong Kok, Hong Kong.

Leadership
Lyn Wade Lu
IPO Date
Jun 9, 2020
Employees
2.9k
Street Address
L 50, Langham Place Office Tower
Mailing
Mong Kok
Region
Mong Kok, HK
Reporting Currency
USD
Investor Line
852 3975 4798
Last Updated
May 5, 2026
ISIN: KYG3037S1021
Reports in USD

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
1.9
Price/Sales
0.1
Price/Book
0.3

Growth

Revenue
-1.7%
EPS
-775.0%
Free Cash Flow
+30.0%

Profitability

Gross Margin
74.8%
Operating Margin
-6.0%
Net Margin
-4.8%
ROE
-10.7%
ROIC
-5.7%

Balance Sheet

Debt/Equity
0.93
Current Ratio
0.83

Earnings Reports

No earnings data available

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.